How to choose between verifiable AI and AI governance, and tell which a vendor actually does.

What does AI governance actually cover?

AI governance is the program-level discipline of documenting policy, risk, and controls across the whole AI lifecycle, and it is necessary, complementary work.

In practice, governance covers the written artifacts and managed processes that establish a defensible program: policies that state how AI may and may not be used, model inventories that record what is in production, risk registers that name hazards and rate them, roles and accountability so someone owns each control, and lifecycle controls that carry a model from design through validation, deployment, monitoring, and retirement. It is the layer that maps most directly to external frameworks. The NIST AI Risk Management Framework gives organizations a voluntary structure for governing, mapping, measuring, and managing AI risk, and the EU Artificial Intelligence Act attaches obligations to systems by risk tier, including record-keeping and human-oversight duties for higher-risk uses. Governance answers whether an organization has done this work: are the risks named, are controls assigned, is there accountability, is there a paper trail a regulator would accept. That is real and load-bearing, and RankShieldMD does not replace it or diminish it. What governance produces, though, is documentation and managed process. It establishes that a program exists and that controls are defined. It does not, on its own, produce per-decision cryptographic proof that a specific decision honored those controls at the moment it was made. That is a different layer, and recognizing the boundary is the first step in choosing well. Governance is where you say what should be true; it is not where you prove, decision by decision, that it was.

What does verifiable AI prove that governance cannot?

Verifiable AI proves, per decision, that a specific model running on specific data produced a specific output, as cryptographic evidence anyone can check after the fact.

Governance can tell you that only approved models are permitted and that controls exist to keep it that way. What it cannot do, by its nature as a documentation layer, is prove that a particular decision your system produced last Tuesday actually came from that approved model, on data that had not been tampered with, and returned the output your record claims. Verifiable AI closes exactly that gap. At the moment a decision is made, it seals the model identity, a digest of the input data, and the output into a single record, then anchors that record to an external, tamper-evident log. Later, a reviewer, an auditor, or a buyer can take the record and recompute it, confirming that nothing was altered after the fact and that the decision matches what the evidence describes, without having to trust a dashboard or take the vendor's word. This is auditable and source-verified by construction rather than by assertion, an approach the published research on clinical-AI decision support describes as integrating verifiable provenance directly into the decision pipeline.^[1] The practical difference is the difference between a policy that says decisions come from an approved model and evidence that this decision did. Verifiable AI does not manage your risk program, write your policies, or maintain your inventories. It proves the decision. RankShieldMD supplies that proof and never renders, scores, or influences the clinical decision itself, which is what keeps it non-device.

Do you need both, and how do the two layers fit together?

Most healthcare buyers need both, because governance sets the policy and risk posture while verifiable AI produces the evidence that the policy was honored at decision time.

The clearest way to see the fit is to watch a single decision travel through both layers. Governance comes first and above: it decides which models are approved for a given use, what controls apply, what oversight is required, and who is accountable if something goes wrong. That is the policy and the risk posture, and it exists whether or not any decision has yet been made. Then a decision is made, and verifiable AI acts at that instant: it captures the model identity, the data digest, and the output, seals them, and anchors the record so that the claim now has evidence behind it. Governance says what should be true; verifiable AI shows it was true, one decision at a time.^[1] Neither layer substitutes for the other, and it helps to see why. A strong governance program with no per-decision proof can describe intent in detail but cannot demonstrate, when challenged, that a specific decision followed the rules, so its assurance rests on narrative. Per-decision proof with no governing program above it produces evidence with no policy to interpret it, verifiable records that no one has decided what to conclude from. Stacked together, they reinforce each other: the program defines the standard, the evidence proves the standard was met. This is why RankShieldMD positions itself as the verifiable-AI layer that produces evidence supporting a governance program, deliberately not as a governance program in its own right. Buying it does not retire your governance obligations, and it is honest about that.

How can you tell whether a vendor proves decisions or only documents risk?

Run a short evaluation checklist: does the tool emit per-decision evidence, can a third party recompute it without trusting the vendor, is it externally anchored, is it PHI-free, and does it attest rather than render.

Vendor language blurs the two layers, so evaluate by mechanism, not by marketing. First, ask what the tool emits when a decision is made. If the output is a dashboard, a report, or an entry in a register, that is program-level documentation, the governance layer. If the output is a discrete, per-decision record tied to that specific inference, that points toward verifiable AI. Second, ask whether a third party can recompute the evidence independently, without access to or trust in the vendor's systems, because evidence that only the vendor can validate is not the same as evidence anyone can check. Third, ask what the record is anchored to: an external, tamper-evident log is far stronger than a record that lives only inside the vendor's own database, where it could in principle be edited. Fourth, ask whether the tool holds protected health information, because a tool that ingests PHI expands your exposure and your covered-entity footprint, whereas a PHI-free design that works on identities and one-way digests shrinks it. Fifth, and most important for classification, ask whether the tool renders or scores the clinical decision, which can pull it across the line into a regulated device, or whether it only attests that a decision was genuine. A vendor whose tool emits recomputable, externally-anchored, PHI-free, attest-only evidence is doing verifiable AI. A vendor whose value is mainly policies, inventories, and reports is doing governance. Both are legitimate and often bought together. The checklist simply lets you tell which one you are actually looking at, so you buy the layer you meant to buy. Naming no vendor, the questions do the sorting for you.

Which layer should a health system, device maker, or AI vendor start with?

Start where the accountability gap is sharpest, because the right first move depends on which question you cannot yet answer.

The practical guidance changes with the buyer. A health system deploying clinical AI it purchased rather than built usually already has some governance in place, an AI policy, a committee, a risk register, and its sharpest gap is proof: when a board member or an auditor asks whether a specific AI-influenced decision was genuine, documentation alone is thin. For that buyer, the verifiable-AI layer is typically the higher-leverage first move, because it converts an existing program into defensible per-decision evidence. A device maker preparing a premarket submission genuinely needs both at once: governance shapes the quality program and the risk posture, while signed evidence, device identity, and a software bill of materials support the filing itself, so the two are pursued in parallel rather than sequenced. An AI vendor selling into healthcare often faces the opposite starting point: buyers first ask for governance maturity, an ISO-aligned program, documented risk management, clear accountability, and per-decision proof then becomes a differentiator that answers the harder follow-up question of whether the vendor can demonstrate, not just describe, that its model behaved as claimed. Across all three, the layers are complementary, never competing, and the decision is one of sequence and emphasis, not of one instead of the other. RankShieldMD supplies the verifiable-AI layer and produces evidence that supports whichever governance program you run, so the choice of where to start does not lock you out of the other layer later. Wherever the sharper gap sits today, close that one first, then let the second layer reinforce it.

References

1. NIST NIST AI Risk Management Framework (AI RMF 1.0). nist.gov/itl/ai-risk-management-framework
2. EU EU Artificial Intelligence Act. artificialintelligenceact.eu
3. [1] Frontiers in Artificial Intelligence (2026). An auditable and source-verified framework for clinical AI decision support. frontiersin.org/journals/artificial-intelligence/…/frai.2026.1737532